Multani Pharmaceuticals Limited - Company Profile

It is a fmcg public limited company based in New Delhi, Delhi, India, established in 1986.
1986 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Multani Pharmaceuticals Limited

Multani Pharmaceuticals Limited, a active public limited company, was established on 05 March 1986 in New Delhi, Delhi, India. Engaging in personal care & skincare products within the manufacturing sector, it holds CIN: U24230DL1986PLC023539. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹2.16 Cr.

Formerly known as Multani Pharmaceuticals P Limited. It upholds a compliant status. Employing 483 professional, Its leadership includes Rajesh Sabharwal (Director), Sanjay Kumar (Director), Pradeep Multani (Director). Past directors included Rajesh Sabharwal, Jagdish Prasad Pandey, Kamal Prasad. It holds ₹49.85 Cr open charges and ₹23.76 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at T-10 Okhla Industrial Area Phase - Ii, New Delhi, Delhi, 110020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230DL1986PLC023539

  • Registration Number

    023539

  • Incorporation Date

    05 March 1986

  • Authorized Capital

    ₹6.00 Cr

  • Paid-Up Capital

    ₹2.16 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.00 Cr
  • Paid Up Capital ₹ 2.16 Cr
  • Company Age 39 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 49.85 Cr
  • Satisfied Charges ₹ 23.76 Cr
  • Revenue Growth **** 19.51%
  • Profit Growth **** -10.51%
  • Ebitda **** -9.79%
  • Net Worth 17.98%
  • Total Assets **** 31.97%
Company report

Multani Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Multani Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Multani Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Rajesh Sabharwal Director 27 Feb 2019 Current
Sanjay Kumar Director 01 Feb 2023 Current
Pradeep Multani Director 08 Mar 1986 Current
Yogesh Sahni Director 27 Feb 2019 Current
Vinay Rungta Director 01 Feb 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Mar 2020 Past
Pramod Abcsdd Director 01 Jun 2012 Past
Pramod Abcsdd Managing Director 02 Feb 2023 Past
Pramod Abcsdd Director 31 Mar 2020 Past
Pramod Abcsdd Additional Director 02 Jun 2012 Past
Pramod Abcsdd Director 31 Mar 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Multani Pharmaceuticals.

Multani Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 19.51% increase. The company also saw a substantial fall in profitability, with a 10.51% decrease in profit. The company's net worth Soared by an impressive increase of 17.98%.

Multani Pharmaceuticals revenue growth over time
Multani Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 19.51%
*******
*******
*******
*******
Revenue from Operations
*******
 18.89%
*******
*******
*******
*******
Total Assets
*******
 31.97%
*******
*******
*******
*******
Profit or Loss
*******
 -10.51%
*******
*******
*******
*******
Net Worth
*******
 17.98%
*******
*******
*******
*******
EBITDA
*******
 -9.79%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Multani Pharmaceuticals?

In 2024, Multani Pharmaceuticals had a promoter holding of 99.94% and a public holding of 0.06%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹498,500,000.00

Satisfied Charges

₹237,558,147.00

Charges Breakdown by Lending Institutions
  • Others : 43.10 Cr
  • Sidbi : 6.75 Cr
Latest Charge Details
Date Lender Amount Status
17 Nov 2025 Sidbi ₹2.25 Cr Open
04 Nov 2025 Sidbi ₹3.00 Cr Open
20 Sep 2025 Others ₹20.00 Cr Open
18 Jan 2021 Sidbi ₹1.50 Cr Open
31 Dec 2002 Others ₹23.10 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Multani Pharmaceuticals?

Multani Pharmaceuticals has a workforce of 483 employees as of Apr 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Multani Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Multani Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Multani Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge with Sidbi amounted to Rs. 2.25 Cr with Charge ID 101197301 was registered on 17 Nov 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Sidbi amounted to Rs. 3.00 Cr with Charge ID 101193445 was registered on 04 Nov 2025. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101162442 was registered on 20 Sep 2025. was documented.

  • Charges

    A charge registered on 19 Jan 2024 via Charge ID 100848799 with Others was fully satisfied on 03 Apr 2025. was recorded as a recent event.

  • Annual General Meeting

    Progress on Multani Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Multani Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Multani Pharmaceuticals Limited?

The CIN of Multani Pharmaceuticals Limited is U24230DL1986PLC023539.

Where is Multani Pharmaceuticals Limited headquartered?

Multani Pharmaceuticals Limited is headquartered at T-10 Okhla Industrial Area Phase - Ii, New Delhi, Delhi, 110020.

When was Multani Pharmaceuticals Limited incorporated?

Multani Pharmaceuticals Limited was incorporated on 05 March 1986.

Who are the current directors of Multani Pharmaceuticals Limited?

The current directors of Multani Pharmaceuticals Limited are

What is the primary industry of Multani Pharmaceuticals Limited?

The primary industry of Multani Pharmaceuticals Limited is Manufacturing.

Is Multani Pharmaceuticals Limited a listed company?

Multani Pharmaceuticals Limited is unlisted.

What is the capital structure of Multani Pharmaceuticals Limited?

The authorized capital of Multani Pharmaceuticals Limited is ₹6.00 Cr, and the paid-up capital is ₹2.16 Cr.

What is the compliance status of Multani Pharmaceuticals Limited?

The compliance status of Multani Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available